Morgan Stanley’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$20.2M Buy
2,497,233
+876,232
+54% +$7.09M ﹤0.01% 2795
2025
Q1
$13.6M Buy
1,621,001
+133,240
+9% +$1.12M ﹤0.01% 3065
2024
Q4
$11.8M Buy
1,487,761
+242,585
+19% +$1.92M ﹤0.01% 3270
2024
Q3
$10.4M Buy
1,245,176
+209,571
+20% +$1.74M ﹤0.01% 3406
2024
Q2
$6.58M Buy
1,035,605
+79,643
+8% +$506K ﹤0.01% 3669
2024
Q1
$5.79M Buy
955,962
+71,376
+8% +$433K ﹤0.01% 3801
2023
Q4
$5.37M Buy
884,586
+508,410
+135% +$3.09M ﹤0.01% 4333
2023
Q3
$1.59M Sell
376,176
-59,349
-14% -$250K ﹤0.01% 4530
2023
Q2
$1.35M Buy
435,525
+53,037
+14% +$164K ﹤0.01% 4652
2023
Q1
$532K Sell
382,488
-3,838,510
-91% -$5.34M ﹤0.01% 5219
2022
Q4
$8.4M Buy
4,220,998
+3,813,489
+936% +$7.59M ﹤0.01% 3247
2022
Q3
$823K Sell
407,509
-54,911
-12% -$111K ﹤0.01% 4993
2022
Q2
$1.47M Buy
462,420
+39,691
+9% +$126K ﹤0.01% 4754
2022
Q1
$1.76M Buy
422,729
+8,649
+2% +$36.1K ﹤0.01% 4608
2021
Q4
$1.98M Buy
414,080
+99,697
+32% +$478K ﹤0.01% 4588
2021
Q3
$1.68M Buy
314,383
+147,054
+88% +$785K ﹤0.01% 4710
2021
Q2
$856K Buy
167,329
+13,005
+8% +$66.5K ﹤0.01% 5175
2021
Q1
$1.04M Sell
154,324
-89,736
-37% -$603K ﹤0.01% 4711
2020
Q4
$1.12M Sell
244,060
-6,978
-3% -$31.9K ﹤0.01% 4593
2020
Q3
$974K Buy
251,038
+163,848
+188% +$636K ﹤0.01% 4230
2020
Q2
$415K Sell
87,190
-8,905
-9% -$42.4K ﹤0.01% 4696
2020
Q1
$334K Sell
96,095
-217,288
-69% -$755K ﹤0.01% 4601
2019
Q4
$1.51M Sell
313,383
-1,717,078
-85% -$8.28M ﹤0.01% 4243
2019
Q3
$5.89M Buy
2,030,461
+1,994,724
+5,582% +$5.79M ﹤0.01% 2685
2019
Q2
$256K Buy
35,737
+7,390
+26% +$52.9K ﹤0.01% 4924
2019
Q1
$402K Sell
28,347
-115,791
-80% -$1.64M ﹤0.01% 4690
2018
Q4
$1.95M Sell
144,138
-133,934
-48% -$1.81M ﹤0.01% 3792
2018
Q3
$6.17M Sell
278,072
-40,128
-13% -$891K ﹤0.01% 2960
2018
Q2
$5.22M Buy
+318,200
New +$5.22M ﹤0.01% 3091